Table: Shin Nippon Biomedical -Q1 group results

Shin Nippon Biomedical Laboratories

09/08/2019 07:01

Aug 9 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             2.73                3.71             14.47    
                 (-26.5 pct)         (+10.0 pct)      (-7.6 pct)  
  Operating        273 mln          loss 141 mln          1.50    
                                                      (+80.8 pct) 
  Recurring        49 mln              558 mln            1.55    
                 (-91.2 pct)                          (-3.9 pct)  
  Net            loss 41 mln           385 mln            1.25    
                                                      (-35.9 pct) 
  EPS           loss 0.99 yen         9.25 yen         30.02 yen  
  Ann Div                             3.00 yen         5.00 yen   
  -Q2 div                                NIL              NIL     
  -Q4 div                             3.00 yen         5.00 yen   
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T